Imagen de Amazon.com
Portada de Syndetics
Imagen de OpenLibrary
Life sciences & chemical patent practice in Canada a practical guide.
Detalles de publicación: [Toronto, ON?] Borden Ladner Gervais LLP c2011.Edición: 3rd. edDescripción: xviii, 184 p. ill. 24 cmISBN:- 9780973075069
- 0973075066
- Life sciences and chemical patent practice in Canada
- KE 2919 .L54 2011
Contenidos:
Overview of the Canadian patent system -- Procedural requirements -- Biotechnology-specific procedural requirements -- Chemical compounds -- Biopolymers : DNA, RNA, and proteins -- Antibodies -- Living matter (life forms) -- Medical treatments and medical uses -- Bioinformatics, diagnostic technologies, and biomarkers -- Plant breeders' rights -- Patented medicines (notice of compliance) regulations -- Patented medicine prices review board -- Subsequent entry biologics -- Infringement, validity, and post-grant modifications.
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Libro | Biblioteca de Derecho Mons. Fremiot Torres Oliver Colección General biblioteca derecho | KE 2919 .L54 2011 (Navegar estantería(Abre debajo)) | Disponible | 70000000894275 |
Total de reservas: 0
Includes bibliographical references and index.
Includes table of cases.
Previous editions titled: Biotechnology and chemical patent practice in Canada.
Overview of the Canadian patent system -- Procedural requirements -- Biotechnology-specific procedural requirements -- Chemical compounds -- Biopolymers : DNA, RNA, and proteins -- Antibodies -- Living matter (life forms) -- Medical treatments and medical uses -- Bioinformatics, diagnostic technologies, and biomarkers -- Plant breeders' rights -- Patented medicines (notice of compliance) regulations -- Patented medicine prices review board -- Subsequent entry biologics -- Infringement, validity, and post-grant modifications.